Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

399 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevalencia de prediabetes y diabetes en México: Ensanut 2022.
Basto-Abreu A, López-Olmedo N, Rojas-Martínez R, Aguilar-Salinas CA, Moreno-Banda GL, Carnalla M, Rivera JA, Romero-Martinez M, Barquera S, Barrientos-Gutiérrez T. Basto-Abreu A, et al. Among authors: aguilar salinas ca. Salud Publica Mex. 2023 Jun 13;65:s163-s168. doi: 10.21149/14832. Salud Publica Mex. 2023. PMID: 38060942 Spanish.
A metagenomic study identifies a Prevotella copri enriched microbial profile associated with non-alcoholic steatohepatitis in subjects with obesity.
Moran-Ramos S, Cerqueda-García D, López-Contreras B, Larrieta-Carrasco E, Villamil-Ramírez H, Molina-Cruz S, Torres N, Sánchez-Tapia M, Hernández-Pando R, Aguilar-Salinas C, Villarreal-Molina T, Canizales-Quinteros S. Moran-Ramos S, et al. J Gastroenterol Hepatol. 2023 May;38(5):791-799. doi: 10.1111/jgh.16147. Epub 2023 Mar 2. J Gastroenterol Hepatol. 2023. PMID: 36807933
HDL abnormalities in type 2 diabetes: Clinical implications.
Martagon AJ, Zubirán R, González-Arellanes R, Praget-Bracamontes S, Rivera-Alcántara JA, Aguilar-Salinas CA. Martagon AJ, et al. Atherosclerosis. 2023 Aug 3:117213. doi: 10.1016/j.atherosclerosis.2023.117213. Online ahead of print. Atherosclerosis. 2023. PMID: 37580206 Review.
Effect of a monitored exercise protocol in cerebral and hepatic hemodynamics in patients with cirrhosis and portal hypertension.
Macías-Rodríguez RU, Ruiz-Margáin A, Román-Calleja B, Cantú-Brito C, Flores-Silva F, Gabutti-Thomas A, Aguilar-Nájera O, Cruz-Contreras M, Weber-Sangri L, Ríos-Torres S, Delgadillo AT, Aguilar-Salinas CA, Kershenobich-Stalnikowitz D. Macías-Rodríguez RU, et al. Dig Liver Dis. 2024 May;56(5):827-835. doi: 10.1016/j.dld.2023.11.011. Epub 2023 Nov 25. Dig Liver Dis. 2024. PMID: 38008698 Clinical Trial.
De-escalating treatment indications for patients who achieve metabolic goals.
Cristina García-Ulloa A, Jaime-Casas S, Rosado-Lozoya J, Serrano-Pérez NH, Hernández-Juárez D, Luis Cárdenas-Fragoso J, Eduardo Briones-García L, Jiménez-Soto R, García-Padilla C, García-Lara J, Aguilar-Salinas CA, Hernández-Jiménez S. Cristina García-Ulloa A, et al. Among authors: aguilar salinas ca. Diabetes Res Clin Pract. 2024 Feb;208:111096. doi: 10.1016/j.diabres.2024.111096. Epub 2024 Jan 18. Diabetes Res Clin Pract. 2024. PMID: 38244782 Free article. Review.
Insulin resistance potentiates the effect of remnant cholesterol on cardiovascular mortality in individuals without diabetes.
Vargas-Vázquez A, Fermín-Martínez CA, Antonio-Villa NE, Fernández-Chirino L, Ramírez-García D, Dávila-López G, Díaz-Sánchez JP, Aguilar-Salinas CA, Seiglie JA, Bello-Chavolla OY. Vargas-Vázquez A, et al. Among authors: aguilar salinas ca. Atherosclerosis. 2024 Mar 13:117508. doi: 10.1016/j.atherosclerosis.2024.117508. Online ahead of print. Atherosclerosis. 2024. PMID: 38570208
Association of a low-frequency variant in HNF1A with type 2 diabetes in a Latino population.
SIGMA Type 2 Diabetes Consortium; Estrada K, Aukrust I, Bjørkhaug L, Burtt NP, Mercader JM, García-Ortiz H, Huerta-Chagoya A, Moreno-Macías H, Walford G, Flannick J, Williams AL, Gómez-Vázquez MJ, Fernandez-Lopez JC, Martínez-Hernández A, Jiménez-Morales S, Centeno-Cruz F, Mendoza-Caamal E, Revilla-Monsalve C, Islas-Andrade S, Córdova EJ, Soberón X, González-Villalpando ME, Henderson E, Wilkens LR, Le Marchand L, Arellano-Campos O, Ordóñez-Sánchez ML, Rodríguez-Torres M, Rodríguez-Guillén R, Riba L, Najmi LA, Jacobs SB, Fennell T, Gabriel S, Fontanillas P, Hanis CL, Lehman DM, Jenkinson CP, Abboud HE, Bell GI, Cortes ML, Boehnke M, González-Villalpando C, Orozco L, Haiman CA, Tusié-Luna T, Aguilar-Salinas CA, Altshuler D, Njølstad PR, Florez JC, MacArthur DG. SIGMA Type 2 Diabetes Consortium, et al. JAMA. 2014 Jun 11;311(22):2305-14. doi: 10.1001/jama.2014.6511. JAMA. 2014. PMID: 24915262 Free PMC article.
399 results